U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607379) titled 'Robotic Dog Intervention on Emotional Well-Being and Quality of Life' on May 18.
Brief Summary: The hematopoietic stem cell transplantation (HSCT) process imposes a substantial psychological burden, leading to impaired emotional well-being due to intensive treatment, isolation, and immunosuppression. Patients often experience social withdrawal, loneliness, and loss of control, which may result in persistent anxiety, depressive symptoms, and reduced quality of life (QoL) if unaddressed. This study aims to evaluate the effectiveness, feasibility, and acceptability of an AI-powered robotic dog in improving emotional well-being and QoL i...